Influences of phenylephrine and orciprenaline on the release of noradrenaline.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D002247:Carbon Isotopes; D003042:Cocaine / Q000494:pharmacology; D004558:Electric Stimulation; D006321:Heart / Q000294:innervation; D066298:In Vitro Techniques; D009921:Metaproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010656:Phenylephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000378:metabolism; D009435:Synaptic Transmission
D000318:Adrenergic beta-Agonists; D002247:Carbon Isotopes; D010643:Phenoxybenzamine; D010656:Phenylephrine; D009921:Metaproterenol; D011433:Propranolol; D003042:Cocaine; D009638:Norepinephrine